About Abegaill
Abegaill is a company based in Rotterdam (Netherlands) founded in 2017. It operates as a HealthTech. Abegaill offers products and services including Ductoscopy Devices. Abegaill operates in a competitive market with competitors including Cianna Medical, Elucent Medical, KUB Technologies, SenoRx and Health Beacons, among others.
- Headquarter Rotterdam, Netherlands
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Abegaill B.V.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Swanbridge Capital
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abegaill
Abegaill offers a comprehensive portfolio of products and services, including Ductoscopy Devices.
Devices for ductoscopy to treat breast disease are developed.
Funding Insights of Abegaill
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2017 | Amount | Seed - Abegaill | Valuation | Swanbridge Capital , Leander Healthcare |
|
Investors in Abegaill
Abegaill has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Swanbridge Capital and Leander Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Leander Healthcare is engaged in distributing medical devices in Benelux.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Abegaill
Financial Statements - Abegaill
Abegaill Comparisons
Competitors of Abegaill
Abegaill operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cianna Medical, Elucent Medical, KUB Technologies, SenoRx and Health Beacons, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Breast brachytherapy devices and surgical guidance systems are developed.
|
|
| domain | founded_year | HQ Location |
Develops smart surgical guidance systems with in-body spatial intelligence for accuracy.
|
|
| domain | founded_year | HQ Location |
Provides medical devices for specimen imaging and gamma probes in healthcare facilities.
|
|
| domain | founded_year | HQ Location |
Minimally Invasive devices for breast cancer treatment & diagnosis
|
|
| domain | founded_year | HQ Location |
Provides an RFID localization system for effective cancer treatment.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterials for immunomodulatory tissue healing are developed.
|
Latest news on Abegaill
Frequently Asked Questions about Abegaill
Abegaill was founded in 2017.
Abegaill is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.
Edwin Leander is the current CEO of Abegaill.
Abegaill B.V. is engaged in the development of medical devices specialized in ductoscopy. The company is aimed at treating pre-malignant and malignant breast diseases through innovative solutions. Based in Rotterdam, Netherlands, it operates within the healthcare sector, focusing on advancing diagnostic and treatment technologies for breast health.
Abegaill's top competitors include Cianna Medical, SenoRx and Polumiros.
Abegaill offers Ductoscopy Devices.
Abegaill has 2 investors. Key investors include Swanbridge Capital, and Leander Healthcare.